Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · Real-Time Price · USD
105.67
-4.49 (-4.08%)
May 13, 2025, 4:00 PM - Market closed
Axsome Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 300.91 | 315.35 | 386.19 | 200.84 | 86.47 | 183.88 | Upgrade
|
| Cash & Short-Term Investments | 300.91 | 315.35 | 386.19 | 200.84 | 86.47 | 183.88 | Upgrade
|
| Cash Growth | -9.21% | -18.34% | 92.29% | 132.26% | -52.97% | -16.41% | Upgrade
|
| Receivables | 161.4 | 142 | 94.82 | 37.7 | - | - | Upgrade
|
| Inventory | 16.32 | 15.73 | 15.14 | 4.32 | - | - | Upgrade
|
| Prepaid Expenses | 16.01 | 11.98 | 8.12 | 2.78 | 0.05 | 0.15 | Upgrade
|
| Total Current Assets | 494.63 | 485.06 | 504.26 | 245.64 | 86.52 | 184.02 | Upgrade
|
| Property, Plant & Equipment | 24.07 | 5.97 | 7.62 | 1.14 | 0.94 | 1.79 | Upgrade
|
| Goodwill | 12.04 | 12.04 | 12.04 | 10.31 | - | - | Upgrade
|
| Other Intangible Assets | 45.32 | 46.89 | 53.29 | 59.66 | - | - | Upgrade
|
| Other Long-Term Assets | 20.61 | 18.53 | 11.03 | 14.72 | 0.32 | 0.32 | Upgrade
|
| Total Assets | 596.67 | 568.5 | 588.24 | 331.48 | 87.79 | 186.13 | Upgrade
|
| Accounts Payable | 85.66 | 72 | 40.68 | 38.61 | 13.15 | 13.5 | Upgrade
|
| Accrued Expenses | 146.42 | 145.61 | 90.5 | 51.63 | 9.3 | 8.71 | Upgrade
|
| Current Portion of Leases | 2.27 | 3.26 | 1.27 | 0.43 | 0.62 | 1.22 | Upgrade
|
| Current Income Taxes Payable | 0.96 | 0.96 | - | - | - | - | Upgrade
|
| Other Current Liabilities | 8.6 | 8.29 | 6.41 | 5.9 | - | - | Upgrade
|
| Total Current Liabilities | 243.91 | 230.1 | 138.85 | 96.56 | 23.07 | 23.44 | Upgrade
|
| Long-Term Debt | 181.38 | 180.71 | 178.07 | 94.26 | 49.09 | 48.32 | Upgrade
|
| Long-Term Leases | 27.59 | 8.99 | 7.04 | - | - | 0.58 | Upgrade
|
| Other Long-Term Liabilities | 90.59 | 91.68 | 73.3 | 31.1 | - | - | Upgrade
|
| Total Liabilities | 543.47 | 511.48 | 397.26 | 221.92 | 72.15 | 72.34 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0.01 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 1,235 | 1,180 | 1,027 | 705.89 | 424.83 | 392.59 | Upgrade
|
| Retained Earnings | -1,182 | -1,123 | -835.57 | -596.33 | -409.2 | -278.8 | Upgrade
|
| Shareholders' Equity | 53.21 | 57.02 | 190.98 | 109.56 | 15.63 | 113.79 | Upgrade
|
| Total Liabilities & Equity | 596.67 | 568.5 | 588.24 | 331.48 | 87.79 | 186.13 | Upgrade
|
| Total Debt | 211.23 | 192.96 | 186.37 | 94.68 | 49.71 | 50.12 | Upgrade
|
| Net Cash (Debt) | 89.68 | 122.4 | 199.82 | 106.16 | 36.76 | 133.75 | Upgrade
|
| Net Cash Growth | -36.85% | -38.75% | 88.23% | 188.77% | -72.51% | -33.13% | Upgrade
|
| Net Cash Per Share | 1.86 | 2.55 | 4.40 | 2.61 | 0.98 | 3.59 | Upgrade
|
| Filing Date Shares Outstanding | 49.24 | 48.77 | 47.37 | 43.52 | 38.48 | 37.41 | Upgrade
|
| Total Common Shares Outstanding | 49.22 | 48.67 | 47.35 | 43.5 | 37.82 | 37.37 | Upgrade
|
| Working Capital | 250.72 | 254.96 | 365.41 | 149.08 | 63.45 | 160.59 | Upgrade
|
| Book Value Per Share | 1.08 | 1.17 | 4.03 | 2.52 | 0.41 | 3.04 | Upgrade
|
| Tangible Book Value | -4.16 | -1.92 | 125.65 | 39.59 | 15.63 | 113.79 | Upgrade
|
| Tangible Book Value Per Share | -0.08 | -0.04 | 2.65 | 0.91 | 0.41 | 3.04 | Upgrade
|
Updated May 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.